Issue |
J Extra Corpor Technol
Volume 7, Number 3, September 1975
|
|
---|---|---|
Page(s) | 140 - 149 | |
DOI | https://doi.org/10.1051/ject/197573140 | |
Published online | 16 October 2023 |
Review Article
Hemodilution with Hydroxyethyl Starch During Cardiopulmonary Bypass: Review of a Multi-Institutional Study
1
From the Departments of Surgery, Nagoya, Kobe, Kurume, and Tokyo Universities, Japan
2
The Medical Affairs Department, McGaw Laboratories, Division of American Hospital Supply Corporation, Glendale, California 91201
Three colloidal plasma expanders for use during cardiopulmonary bypass were compared in 85 patients treated at four Japanese hospitals. Patients were randomly allocated to receive: Hydroxyethyl Starch (HES) 5 ml/kg, HES 10 ml/kg, gelatin (Haemacel 10 ml/kg), or a mixture of HES 5 ml/kg and low viscosity dextran (LVD) 5 ml/kg, in addition to the usual priming dose of 1000-1500 ml Lactated Ringer's solution, 20 gm/dl mannitol, and heparinized whole blood. These colloidal plasma expanders appeared equivalent in safely replacing whole blood. Following surgery, urine outputs increased slightly, there were transient elevations of SGOT, LDH, and serum bilirubin, and transient decrements in serum alkaline phosphatase, Na, K, and Cl concentrations. Serum protein, one week following surgery was decreased, possibly reflecting persistence of the plasma expanders. There was no increased bleeding or prolongation of clotting times, bleeding times, or prothrombin times, even though platelet counts were low following surgery. Plasma hemoglobin concentrations were greater in patients receiving gelatin as compared with those given HES. Hydroxyethyl Starch (6 gm/dl), a new plasma expander, appears to be efficacious and nontoxic in hemodilution extracorporeal perfusion.
The priming solution employed in the extracorporeal circuit has undergone refinement to limit denaturation of blood and consequent clinical sequelae.5,29,30,40 Initially, heparinized whole blood primed the circuit, but the possibility of incompatible blood administration, transmission of viral hepatitis, and nonhemolytic reactions of a febrile or allergic nature became apparent with the use of homologous blood.10,23 Development and improvement of colloidal and crystalloid solutions for hemodilution, has conserved blood and prevented adverse effects attendant upon blood transfusion.12,19,21,24 The use of hemodilution has allowed prolongation of the perfusion period, expanding the application of open heart surgery.21
The present study compares the efficacy and toxicity of hydroxyethyl starch (HES) and gelatin in 85 patients during open heart surgery.
© 1975 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.